Immediate Impact

59 standout
Sub-graph 1 of 23

Citing Papers

Advanced materials in sorbent-based analytical sample preparation
2024 Standout
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
2 intermediate papers

Works of Jonathan P. Orme being referenced

Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
2018

Author Peers

Author Last Decade Papers Cites
Jonathan P. Orme 112 92 98 12 180
Deborah Ayeni 96 112 88 7 202
David A. Kircher 66 193 107 11 259
Robert Wappel 39 166 73 9 259
Fariba Ghaidi 103 178 46 11 279
Kunrui Zhu 34 130 62 9 218
Yuwen Cai 45 104 103 11 272
Giuliana Pavone 55 123 100 17 257
D. Lucas Kerr 41 127 70 10 193
Savita Ubhayakar 50 74 46 10 127
Paul Westwood 48 96 69 9 183

All Works

Loading papers...

Rankless by CCL
2026